Daniel C. Adelman

Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer

Michael S. Gordon, Kim Margolin, Moshe Talpaz et al. · Journal of Clinical Oncology · 2001 · 919 citations

Medicine, Oncology, Pharmacology +17

Phase Ib Trial of Intravenous Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor in Combination With Chemotherapy in Patients With Advanced Cancer: Pharmacologic and Long-Term Safety Data

Kim Margolin, Michael Gordon, Eric Holmgren et al. · Journal of Clinical Oncology · 2001 · 367 citations

Pharmacy, Oncology, Pharmacology +17

Glutenase ALV003 Attenuates Gluten-Induced Mucosal Injury in Patients With Celiac Disease

Marja‐Leena Lähdeaho, Katri Kaukinen, Kaija Laurila et al. · Gastroenterology · 2014 · 253 citations · Full text

Medicine, Nutrition, Pathology +12

Down-Regulation of Human Basophil IgE and FCεRIα Surface Densities and Mediator Release by Anti-IgE-Infusions Is Reversible In Vitro and In Vivo

Sarbjit S. Saini, Donald W. MacGlashan, Sherry A. Sterbinsky et al. · The Journal of Immunology · 1999 · 179 citations

Life Sciences, Immunology, Allergy +12

Imipenem cross-reactivity with penicillin in humans

Andrew Saxon, Daniel C. Adelman, Richard Hajdu et al. · Journal of Allergy and Clinical Immunology · 1988 · 165 citations

Life Sciences, Infectious Diseases, Microbiology +12